We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+22.01%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$19.1B
AUM Growth
+$2.74B
Cap. Flow
-$133M
Cap. Flow %
-0.7%
Top 10 Hldgs %
36.58%
Holding
315
New
39
Increased
84
Reduced
103
Closed
37

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$270M
2
PANW icon
Palo Alto Networks
PANW
+$111M
3
SNOW icon
Snowflake
SNOW
+$104M
4
RMBS icon
Rambus
RMBS
+$103M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.5M

Sector Composition

Rank Sector Weight
1 Technology 39.81%
2 Healthcare 20.96%
3 Financials 13.96%
4 Industrials 10.11%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
101
Interactive Brokers
IBKR
$41.1B
$39.6M 0.21%
1,417,920
+468,784
+49% +$11.7M
RLI icon
102
RLI Corp
RLI
$5.63B
$38.6M 0.2%
520,000
ITGR icon
103
Integer Holdings
ITGR
$4.28B
$38.3M 0.2%
+328,668
New +$34.9M
ICE icon
104
Intercontinental Exchange
ICE
$88.4B
$35.6M 0.19%
259,162
+2,860
+1% +$380K
GLOB icon
105
Globant
GLOB
$1.75B
$35.3M 0.19%
174,876
+6,368
+4% +$1.43M
ALNY icon
106
Alnylam Pharmaceuticals
ALNY
$33.5B
$35.1M 0.18%
235,000
+50,000
+27% +$8.34M
TRUP icon
107
Trupanion
TRUP
$1.09B
$34.5M 0.18%
1,250,000
DXCM icon
108
DexCom
DXCM
$31.3B
$33.7M 0.18%
243,000
-1,667
-0.7% -$210K
MDGL icon
109
Madrigal Pharmaceuticals
MDGL
$12.3B
$33.4M 0.18%
+125,205
New +$29.5M
ICLR icon
110
Icon
ICLR
$13.1B
$32.6M 0.17%
97,090
+46,574
+92% +$13.7M
IMCR icon
111
Immunocore
IMCR
$1.68B
$32.6M 0.17%
501,300
BDX icon
112
Becton Dickinson
BDX
$48.4B
$32.2M 0.17%
130,177
+68,673
+112% +$16.4M
CGON icon
113
CG Oncology
CGON
$6.41B
$32M 0.17%
+729,166
New +$29.8M
LIN icon
114
Linde
LIN
$214B
$31.3M 0.16%
67,405
-18,912
-22% -$8.19M
MMSI icon
115
Merit Medical Systems
MMSI
$5.2B
$31.3M 0.16%
412,765
-65,577
-14% -$5.06M
BRO icon
116
Brown & Brown
BRO
$22.1B
$30.6M 0.16%
+350,000
New +$28.1M
PLRX icon
117
Pliant Therapeutics
PLRX
$72.4M
$30M 0.16%
2,015,000
YMAB
118
DELISTED
Y-mAbs Therapeutics
YMAB
$29.8M 0.16%
1,831,000
-225,872
-11% -$3.04M
NAMS icon
119
NewAmsterdam Pharma
NAMS
$2.67B
$29.6M 0.16%
+1,252,586
New +$25.4M
VERA icon
120
Vera Therapeutics
VERA
$2.45B
$29.1M 0.15%
675,000
-50,000
-7% -$1.78M
LBPH
121
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$28.2M 0.15%
1,305,431
+305,431
+31% +$6.66M
ADI icon
122
Analog Devices
ADI
$175B
$28.1M 0.15%
142,042
-12,388
-8% -$2.38M
ESTA icon
123
Establishment Labs
ESTA
$2.14B
$27.8M 0.15%
546,519
+320,000
+141% +$12.8M
PRA
124
DELISTED
ProAssurance
PRA
$27.8M 0.15%
2,162,500
PODD icon
125
Insulet
PODD
$9.56B
$27.8M 0.15%
161,943
+50,972
+46% +$9.51M

Similar funds

Polar Capital Holdings's Q1 2024 Portfolio in Review

As of Q1 2024, Polar Capital Holdings held 315 positions worth $19.1B, up 17% from $16.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Polar Capital Holdings's Q1 2024 filing shows 39 new, 84 increased, 103 reduced and 37 closed positions. Its largest new stake was Applied Materials: 519,332 shares worth $107M. The largest sale was Apple, an estimated $270M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital Holdings's largest Q1 2024 buy was Applied Materials: 519,332 shares worth $107M.
  • Polar Capital Holdings added most to Meta Platforms (Facebook) in Q1 2024, an estimated $214M increase.
  • Polar Capital Holdings's biggest Q1 2024 reduction was Apple, cutting an estimated $270M.
  • Polar Capital Holdings fully exited Rambus in Q1 2024, selling an estimated $103M.
  • Polar Capital Holdings's ten largest holdings make up 37% of its $19.1B portfolio in Q1 2024.
  • Polar Capital Holdings opened 39 new positions and closed 37 in Q1 2024.
  • Polar Capital Holdings's portfolio value rose 17% quarter-over-quarter to $19.1B.

Based on Polar Capital Holdings's 13F filing for Q1 2024, filed 15 May 2024.